Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
Department of Translational Medicine, Lund University, Wallenberg Laboratory Floor 5, Clinical Research Centre, Malmö, Sweden.
Department of Translational Medicine, Lund University, Wallenberg Laboratory Floor 5, Clinical Research Centre, Box 50332, Malmö, Sweden; Institute of Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID-id: 0000-0001-6808-4405
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; Section for Cervical Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Visa övriga samt affilieringar
2023 (Engelska)Ingår i: Journal of the National Cancer Institute, ISSN 0027-8874, E-ISSN 1460-2105, Vol. 115, nr 4, s. 456-467Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Studies of obesity with or without metabolic aberrations, commonly termed metabolically unhealthy or healthy obesity, in relation to cancer risk are scarce.

Methods: We investigated body mass index (normal weight, overweight, obesity) jointly and in interaction with metabolic health status in relation to obesity-related cancer risk (n = 23630) among 797193 European individuals. A metabolic score comprising mid-blood pressure, plasma glucose, and triglycerides was used to define metabolically healthy and unhealthy status. Hazard ratios (HRs) and multiplicative interactions were assessed using Cox regression, and additive interactions were assessed using the relative excess risk for interaction. All statistical tests were 2-sided.

Results: Metabolically unhealthy obesity, with a baseline prevalence of 7%, was, compared with metabolically healthy normal weight, associated with an increased relative risk of any obesity-related cancer and of colon, rectal, pancreas, endometrial, liver, gallbladder, and renal cell cancer (P <. 05), with the highest risk estimates for endometrial, liver, and renal cell cancer (HR = 2.55-3.00). Metabolically healthy obesity showed a higher relative risk for any obesity-related cancer and colon (in men), endometrial, renal cell, liver, and gallbladder cancer, though the risk relationships were weaker. There were no multiplicative interactions, but there were additive, positive interactions between body mass index and metabolic health status on obesity-related and rectal cancer among men and on endometrial cancer (P <. 05).

Conclusions: This study highlights that the type of metabolic obesity phenotype is important when assessing obesity-related cancer risk. In general, metabolic aberrations further increased the obesity-induced cancer risk, suggesting that obesity and metabolic aberrations are useful targets for prevention.

Ort, förlag, år, upplaga, sidor
Oxford University Press, 2023. Vol. 115, nr 4, s. 456-467
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:umu:diva-211797DOI: 10.1093/jnci/djad008ISI: 000941199500001PubMedID: 36647199Scopus ID: 2-s2.0-85150040100OAI: oai:DiVA.org:umu-211797DiVA, id: diva2:1782017
Forskningsfinansiär
Cancerfonden, CAN 2017/1019Tillgänglig från: 2023-07-12 Skapad: 2023-07-12 Senast uppdaterad: 2023-07-12Bibliografiskt granskad

Open Access i DiVA

fulltext(1466 kB)52 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1466 kBChecksumma SHA-512
670a789412ff8c5fafde9b4138756184ec337e3d79e10c75170d8e9b0929fa92551c0d7a5bb7abbb05358a6f663aedd9164c721387b014822ba961b2b22646f4
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Häggström, Christelvan Guelpen, Bethany

Sök vidare i DiVA

Av författaren/redaktören
Häggström, Christelvan Guelpen, Bethany
Av organisationen
Institutionen för folkhälsa och klinisk medicinWallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)Onkologi
I samma tidskrift
Journal of the National Cancer Institute
Cancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 52 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 185 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf